Global Diabetic Assays Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 3.38 Billion |
 Market Size (Forecast Year) |
USD 4.80 Billion |
 CAGR |
% |
| Major Markets Players |
|
全球糖尿病检测市场，按方法（ELISA、即时诊断检测、酶促测定、比色测定等）、产品类型（仪器、检测试剂盒和试剂）、疾病类型（1 型糖尿病、2 型糖尿病和妊娠期糖尿病）、最终用户（医院、家庭护理、专科诊所等）、分销渠道（医院药房、网上药房和零售药房）划分 - 行业趋势和预测至 2031 年。
糖尿病检测市场分析及规模
糖尿病检测市场继续随着尖端技术的发展而发展，提高了糖尿病诊断和管理的准确性和效率。最新的方法，如自动免疫测定和即时检测，正在改变患者护理，提供更快的结果并降低医疗成本。这种增长是由全球糖尿病病例的增加推动的，推动了全球医疗保健系统创新和采用下一代诊断工具。例如，联合国预计 2017 年五分之一的糖尿病患者年龄超过 65 岁。美国老年人口中糖尿病病例的增加引领了市场增长。
2023 年全球糖尿病检测市场规模价值 33.8 亿美元，预计到 2031 年将达到 48 亿美元，2024 年至 2031 年预测期内的复合年增长率为 4.50%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022 (可定制为 2016-2021) |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
方法（ELISA、即时检测、酶促测定、比色测定等）、产品类型（仪器、检测试剂盒和试剂）、疾病类型（1 型糖尿病、2 型糖尿病和妊娠糖尿病）、部署（自动和手动）、最终用户（医院、家庭护理、专科诊所等）、分销渠道（医院药房、网上药房和零售药房） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区。 |
|
涵盖的市场参与者 |
Abbvie, Inc（美国）、Novartis AG（瑞士）、Teva Pharmaceutical Industries Ltd（以色列）、辉瑞公司（美国）、默克集团（美国）、雅培（美国）、西门子医疗私人有限公司（德国）、Dynatronics Corporation（美国）、BIOMÉRIEUX（法国）、Bio-Rad Laboratories, Inc.（美国）、BAG Diagnostics GmbH（德国）、DiaSorin SpA（意大利）、DRG INSTRUMENTS GMBH（德国）、PTS Diagnostics（美国）、Ortho Clinical Diagnostics（美国）、Diazyme Laboratories, Inc.（美国）、ETHOS BIOSCIENCES（美国）、Abnova Corporation（台湾）和 Monobind Inc.（美国） |
|
市场机会 |
|
市场定义
糖尿病检测是指用于测量与糖尿病相关的各种生物标志物的诊断测试，例如血糖水平、胰岛素和糖化血红蛋白 (HbA1c)。这些检测对于诊断糖尿病、监测治疗效果和评估整体葡萄糖代谢至关重要。它们涉及免疫测定、酶测定和色谱法等技术，以便在临床环境中准确 量化这些生物标志物。
糖尿病检测市场动态
驱动程序
- 糖尿病患病率上升
全球糖尿病患病率的不断上升是诊断检测市场的重要驱动因素。随着全球糖尿病发病率的上升，对先进诊断检测的需求也随之激增，以准确监测血糖水平并评估糖尿病相关的生物标志物。例如，国际糖尿病联合会报告称，2023 年全球有超过 5 亿人患有糖尿病，这凸显了对有效诊断工具来管理和治疗这种慢性疾病的迫切需求，从而推动了市场增长。
- 即时诊断检测 (POCT) 需求不断增长
即时诊断 (POCT) 需求的不断增长是糖尿病检测市场增长的重要驱动力。POCT 满足了对快速结果和分散检测日益增长的需求，改善了患者的治疗效果和医疗效率。例如，雅培 FreeStyle Libre 等血糖监测设备可提供实时血糖读数，使患者无需传统的实验室检查即可更有效地管理糖尿病。这种追求便利性和即时性的趋势正在推动全球市场扩张。
机会
- 提高糖尿病检测中的 IT 集成度
Increasing IT integration systems is transforming the diabetic assays market by enhancing diagnostic capabilities and efficiency. For instance, cloud-based platforms enable real-time data access, improving patient monitoring and treatment management. Electronic health records (EHR) integration ensures seamless information flow among healthcare providers, optimizing care coordination. Furthermore, telemedicine advancements enable remote consultations and data-driven insights, empowering healthcare professionals to deliver personalized diabetes management strategies. These digital innovations drive market growth by improving diagnostic accuracy and patient outcomes.
- Advancement in Technology
Technological advancements in diabetic assays, such as biosensors and rapid testing methods, significantly enhance accuracy and convenience, driving market growth. For instance, continuous glucose monitoring (CGM) systems such as Abbott's FreeStyle Libre use biosensor technology to provide real-time glucose readings without the need for fingerstick tests. These innovations not only improve patient compliance but also support healthcare providers in managing diabetes more effectively, thus expanding the diabetic assays market globally.
Restraints/Challenges
- High Development Costs
High development costs associated with research, clinical trials, and regulatory submissions for diabetic assays deter smaller companies from entering the market and limit innovation. These financial barriers restrict competition and potentially stifle advancements in assay technologies. As a result, the market may lack diversity in products and pricing strategies, hindering overall market growth and the ability to meet evolving healthcare needs effectively.
- Limited Healthcare Infrastructure
Limited healthcare infrastructure in developing regions restricts diabetic assay adoption due to inadequate diagnostic facilities, healthcare professional training, and reimbursement policies. These challenges impede market growth by limiting access to essential testing and hindering effective management of diabetes through diagnostics.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In February 2020, Abbott (US) received US FDA approval for the FreeStyle Libre 14-day Flash glucose monitoring systems for hospital use, enhancing glucose monitoring capabilities in clinical settings
- Also in February 2020, Insulet (US) entered a commercialization agreement with DexCom, Inc. (US) to integrate its current and future CGM systems with DexCom's OMNIPOD Horizon tubeless insulin pump system
- In April 2020, Ypsomed (Switzerland) partnered with DexCom, Inc. (US) to integrate mylife YpsoPump data with DexCom's G6 CGM sensors, aiming to develop a hybrid closed-loop solution for diabetes management
- In January 2020, LifeScan (US) collaborated with DKSH to enhance marketing, sales, regulatory services, and distribution of LifeScan products across Southeast Asia, Hong Kong, and Taiwan, focusing on improving diabetes care access
Diabetic Assays Market Scope
The market is segmented on the basis of method, product type, disease type, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Method
- ELISA
- Point of Care Testing
- Enzymatic Assay
- Colorimetric Assay
- Others
Product Type
- Instruments
- Testing Kits
- Reagent
Disease Type
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
End-Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Diabetic Assays Market Market Regional Analysis/Insights
The market is analysed and market size insights and trends are provided by country, method, product type, disease type, end-users and distribution channel as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to show significant growth in the diabetic assays market due to increasing diabetes prevalence in the U.S. This necessitates higher demand for assays to detect and identify diabetes cases, driving market expansion throughout the forecasted period.
由于新兴经济条件和供应商投资增加，亚太地区有望在糖尿病检测市场占据主导地位。这些因素促进了糖尿病检测的广泛发展，满足了该地区日益增长的医疗保健需求和技术进步。该地区的积极主动方式使其成为推动全球糖尿病诊断和管理解决方案发展的关键参与者。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
该市场还为您提供每个国家/地区资本设备医疗支出增长、市场上不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对市场的影响的详细市场分析。数据适用于 2016-2021 年的历史时期。
竞争格局和糖尿病检测市场份额分析
市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
市场上的一些主要参与者包括：
- Abbvie, Inc（美国）
- 诺华公司（瑞士）
- 梯瓦制药工业有限公司 (以色列)
- 辉瑞公司（美国）
- 默克集团（美国）
- 雅培（美国）
- 西门子医疗私人有限公司（德国）
- Dynatronics 公司 (美国)
- 生物梅里埃（法国）
- Bio-Rad Laboratories, Inc.（美国）
- BAG Diagnostics GmbH（德国）
- DiaSorin SpA（意大利）
- DRG INSTRUMENTS GMBH（德国）
- PTS Diagnostics（美国）
- Ortho Clinical Diagnostics（美国）
- Diazyme Laboratories, Inc.（美国）
- ETHOS BIOSCIENCES（美国）
- 上元科技股份有限公司 (台湾)
- Monobind Inc.（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
